Oxaliplatin Benefit in Stage III Colon Cancer According to IDEA Risk Groups
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Colorectal Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Benefit of Oxaliplatin in Stage III Colon Cancer According to IDEA Risk Groups: Findings From the ACCENT Database of 4934 Patients
Clin Colorectal Cancer 2021 Jun 01;20(2)130-136, O Margalit, B Boursi, M Rakez, A Thierry, G Yothers, N Wolmark, DG Haller, HJ Schmoll, Q Shi, E Shacham-Shmueli, A de GramontFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.